What is Binovi Technologies Corp?
engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally.
BNVIF · Verdict
Limited reward · elevated risk
BNVIF stands out on volatility and valuation, but watch the balance sheet signal.
Based on 88% data coverage
BNVIF · Verdict
Top decile vs peers
Above average
Current ratio 0.32
-1166% free-cash-flow margin
Rev -34.6% CAGR · earnings +50.8%
-8790% net margin · -441% ROE
Model-based scoring. For information only — not financial advice.
engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally. The company's products include Binovi Touch, a tool for vision therapy and vision training; Binovi Pro, which allows doctors/trainers to manage various aspects of patient/athlete's vision training regimens, track progress, and plan and assign protocols; Binovi Coach, a tool that allows users to complete their assigned activities through clear multimedia guidance; and Binovi Academy, an educational hub. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 13.31K.
The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.